A Deep Dive into the SGN-70 Vorsetuzumab represents a significant strategy in cancer, specifically targeting the CD22 protein expressed on malignant blood cells. Developed by the researchers, this antibody functions as an ADCC mechanism inducer, triggerin… Read More